HEADER HYDROLASE 21-AUG-17 5QCD TITLE CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S WITH BOUND LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN S; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.22.27; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSS; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS D3R, CATHEPSIN S, LIGAND DOCKING, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.D.BEMBENEK,M.K.AMERIKS,T.MIRZADEGAN,H.YANG,C.SHAO,S.K.BURLEY REVDAT 5 17-NOV-21 5QCD 1 REMARK REVDAT 4 10-FEB-21 5QCD 1 AUTHOR JRNL REVDAT 3 06-JUN-18 5QCD 1 REMARK ATOM REVDAT 2 21-FEB-18 5QCD 1 REMARK REVDAT 1 20-DEC-17 5QCD 0 JRNL AUTH S.D.BEMBENEK,M.K.AMERIKS,T.MIRZADEGAN,H.YANG,C.SHAO, JRNL AUTH 2 S.K.BURLEY JRNL TITL CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S WITH BOUND LIGAND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 17374 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 876 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.4057 - 3.5430 1.00 2815 149 0.1357 0.1711 REMARK 3 2 3.5430 - 2.8127 1.00 2806 145 0.1428 0.1910 REMARK 3 3 2.8127 - 2.4573 1.00 2761 156 0.1608 0.2134 REMARK 3 4 2.4573 - 2.2327 1.00 2767 157 0.1701 0.2166 REMARK 3 5 2.2327 - 2.0727 1.00 2786 128 0.1639 0.1920 REMARK 3 6 2.0727 - 1.9505 0.93 2563 141 0.1888 0.2320 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.810 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1820 REMARK 3 ANGLE : 0.807 2469 REMARK 3 CHIRALITY : 0.049 244 REMARK 3 PLANARITY : 0.005 315 REMARK 3 DIHEDRAL : 12.860 1050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5QCD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1001401770. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17374 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.951 REMARK 200 RESOLUTION RANGE LOW (A) : 32.401 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE PH 4.5, 200MM REMARK 280 AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 4.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.47600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.66450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.47600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.66450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1127 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1257 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 0 CG1 CG2 CD1 REMARK 470 LYS A 98 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1182 O HOH A 1230 2.07 REMARK 500 O HOH A 1076 O HOH A 1236 2.13 REMARK 500 O HOH A 1119 O HOH A 1220 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1195 O HOH A 1195 2654 1.52 REMARK 500 O HOH A 1200 O HOH A 1200 2655 1.85 REMARK 500 O HOH A 1268 O HOH A 1269 4554 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 58 -124.11 -120.45 REMARK 500 LYS A 177 105.92 -46.79 REMARK 500 LYS A 202 65.62 -116.79 REMARK 500 CYS A 206 19.75 58.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BHJ A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 902 DBREF 5QCD A 0 217 UNP P25774 CATS_HUMAN 114 331 SEQADV 5QCD SER A 25 UNP P25774 CYS 139 ENGINEERED MUTATION SEQADV 5QCD LEU A 218 UNP P25774 EXPRESSION TAG SEQADV 5QCD GLN A 219 UNP P25774 EXPRESSION TAG SEQADV 5QCD GLY A 220 UNP P25774 EXPRESSION TAG SEQADV 5QCD GLY A 221 UNP P25774 EXPRESSION TAG SEQADV 5QCD GLY A 222 UNP P25774 EXPRESSION TAG SEQRES 1 A 223 ILE LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS SEQRES 2 A 223 VAL THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA SER SEQRES 3 A 223 TRP ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU SEQRES 4 A 223 LYS LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN SEQRES 5 A 223 ASN LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS SEQRES 6 A 223 GLY CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR SEQRES 7 A 223 ILE ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR SEQRES 8 A 223 PRO TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER SEQRES 9 A 223 LYS TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU SEQRES 10 A 223 PRO TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA SEQRES 11 A 223 ASN LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS SEQRES 12 A 223 PRO SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU SEQRES 13 A 223 PRO SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL SEQRES 14 A 223 VAL GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU SEQRES 15 A 223 VAL LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY SEQRES 16 A 223 TYR ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY SEQRES 17 A 223 ILE ALA SER PHE PRO SER TYR PRO GLU ILE LEU GLN GLY SEQRES 18 A 223 GLY GLY HET BHJ A 901 49 HET SO4 A 902 5 HETNAM BHJ {(3S)-7-[(2-CHLORO-5-{5-(METHYLSULFONYL)-1-[3- HETNAM 2 BHJ (MORPHOLIN-4-YL)PROPYL]-4,5,6,7-TETRAHYDRO-1H- HETNAM 3 BHJ PYRAZOLO[4,3-C]PYRIDIN-3-YL}PHENYL)ETHYNYL]-1,2,3,4- HETNAM 4 BHJ TETRAHYDROISOQUINOLIN-3-YL}(PIPERIDIN-1-YL)METHANONE HETNAM SO4 SULFATE ION FORMUL 2 BHJ C37 H45 CL N6 O4 S FORMUL 3 SO4 O4 S 2- FORMUL 4 HOH *270(H2 O) HELIX 1 AA1 ARG A 8 GLY A 11 5 4 HELIX 2 AA2 ALA A 24 GLY A 43 1 20 HELIX 3 AA3 SER A 49 SER A 57 1 9 HELIX 4 AA4 THR A 58 GLY A 62 5 5 HELIX 5 AA5 LYS A 64 GLY A 68 5 5 HELIX 6 AA6 PHE A 70 LYS A 82 1 13 HELIX 7 AA7 ASP A 102 LYS A 104 5 3 HELIX 8 AA8 ARG A 120 LYS A 131 1 12 HELIX 9 AA9 HIS A 142 TYR A 148 1 7 HELIX 10 AB1 ASN A 204 ILE A 208 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 HIS A 164 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA1 3 VAL A 134 VAL A 138 -1 N VAL A 134 O VAL A 168 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 HIS A 164 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA2 5 LYS A 177 LYS A 183 -1 O LYS A 183 N LEU A 167 SHEET 4 AA2 5 TYR A 195 ALA A 199 -1 O MET A 198 N TRP A 180 SHEET 5 AA2 5 VAL A 152 TYR A 153 1 N TYR A 153 O ARG A 197 SHEET 1 AA3 2 ILE A 84 ASP A 85 0 SHEET 2 AA3 2 ARG A 106 ALA A 108 -1 O ALA A 107 N ILE A 84 SHEET 1 AA4 2 LYS A 112 GLU A 115 0 SHEET 2 AA4 2 SER A 213 GLU A 216 -1 O GLU A 216 N LYS A 112 SSBOND 1 CYS A 22 CYS A 66 1555 1555 2.05 SSBOND 2 CYS A 56 CYS A 99 1555 1555 2.03 SSBOND 3 CYS A 158 CYS A 206 1555 1555 2.01 SITE 1 AC1 21 LEU A 40 ASN A 67 GLY A 68 GLY A 69 SITE 2 AC1 21 PHE A 70 MET A 71 THR A 73 TYR A 118 SITE 3 AC1 21 ASN A 161 VAL A 162 ASN A 163 HIS A 164 SITE 4 AC1 21 GLY A 165 ASN A 175 PHE A 211 SO4 A 902 SITE 5 AC1 21 HOH A1020 HOH A1076 HOH A1105 HOH A1113 SITE 6 AC1 21 HOH A1127 SITE 1 AC2 11 GLN A 19 GLY A 23 ALA A 24 SER A 25 SITE 2 AC2 11 ASN A 163 HIS A 164 TRP A 186 BHJ A 901 SITE 3 AC2 11 HOH A1001 HOH A1075 HOH A1113 CRYST1 76.952 73.329 44.594 90.00 103.97 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012995 0.000000 0.003232 0.00000 SCALE2 0.000000 0.013637 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023108 0.00000